Vilacto Bio Inc. announced earnings results for the second quarter and half year ended September 30, 2018. For the second quarter, the company announced operating loss was USD 111,011 compared to USD 57,235 a year ago. Net loss was USD 2.324 million compared to USD 58,861 a year ago. Basic loss per share was USD 0.03 compared to Basic EPS of USD 0 a year ago. For the half year, operating loss was USD 228,491 compared to USD 129,035 a year ago. Net loss was USD 2.272 million compared to USD 131,891 a year ago. Basic loss per share was USD 0.03 compared to Basic EPS of USD 0 a year ago.